Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,284 | 1,320 | 02.11. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
25.10. | Disclosure as attachment of the Nanoform 2022 Report of the Board of Directors and Financial Statements which were previously linked to a Company Release | 2 | Cision News | ||
22.10. | Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 | 1 | Cision News | ||
05.09. | Nanoform and Celanese Expand Collaboration into Long-Acting Biologics Delivery Through Small Implants | 5 | Cision News | ||
29.08. | Nanoform Q2 report: All business targets for 2024 on track | 1 | Cision News | ||
16.08. | Invitation to Nanoform's Q2 2024 Report Presentation | 1 | Cision News | ||
15.08. | Nanoform Collaborates with Takeda on Plasma-derived Therapy Development | 14 | Contract Pharma | ||
15.08. | NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT | 748 | PR Newswire | HELSINKI, Aug. 15, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development... ► Artikel lesen | |
14.06. | Nanoform Finland Plc - Manager's Transactions - Miguel Calado | 1 | Cision News | ||
14.06. | Nanoform Finland Plc - Manager's Transactions - Albert Hæggström | 3 | Cision News | ||
14.06. | Share subscriptions based on the resolution by Nanoform Finland Plc's Annual General Meeting 2024 on remuneration of the Board of Directors | 1 | Cision News | ||
14.06. | Nanoform Finland Plc - Manager's Transactions - Mads Laustsen | 1 | Cision News | ||
14.06. | Nanoform Finland Plc - Manager's Transactions - Jeanne Thoma | 1 | Cision News | ||
30.05. | Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned | 495 | PR Newswire | HELSINKI, May 30, 2024 /PRNewswire/ -- Manufacturing of GMP material in Project Nanoenzalutamide commenced. EU/US pivotal studies are planned to start in 4Q24, with the read-out in 1Q25.... ► Artikel lesen | |
29.05. | NANOFORM: Disclosure of Major Holdings under Law 163/2024 | 1 | Cision News | ||
16.05. | Invitation to Nanoform's Q1 2024 Report Presentation | 2 | Cision News | ||
09.04. | Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer | 734 | PR Newswire | Nanoform Finland Plc
April 9, 2024
09.00 EEST / 08.00 CEST
HELSINKI, April 9, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company... ► Artikel lesen | |
15.02. | Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines | 618 | PR Newswire | THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF... ► Artikel lesen | |
26.01. | Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide | 676 | PR Newswire | THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF... ► Artikel lesen | |
05.01. | Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide | 888 | PR Newswire | HELSINKI, Jan. 5, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance enhancing company, today announced it had completed the First Subject First Visit (FSFV)... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 49,300 | +6,02 % | Unglaubliche Prognose für Montag setzt Formycon Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
ONTO INNOVATION | 163,00 | +0,62 % | Onto Innovation Reports 2024 Third Quarter Results | WILMINGTON, Mass.--(BUSINESS WIRE)--Onto Innovation Inc. (NYSE: ONTO) ("Onto Innovation," "Onto," or the "Company") today announced financial results for the third fiscal quarter of 2024.
Third... ► Artikel lesen | |
RIBER | 2,640 | -0,38 % | RIBER: Solid Business Growth at End-September 2024 | SOLID BUSINESS GROWTH AT END-SEPTEMBER 2024 Revenues up +14% to €18.5mOrder book strengthened to €38.3m (+14%) Bezons, October 30, 2024 - 8:00am - RIBER, the global leader for molecular beam epitaxy... ► Artikel lesen | |
GAUZY | 8,950 | -4,28 % | Gauzy Ltd. adds Second Production Shift in Europe to Meet Strong Global Demand; Releases Preliminary Third Quarter Revenue Range and Provides Fourth Quarter Guidance | TEL AVIV, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control solutions, today announced that it has added a... ► Artikel lesen | |
KOPIN | 0,662 | -9,88 % | Kopin Aktie: Kursverlust trotz positiver Monatsbilanz | Die Kopin Corporation, ein global agierendes Nano-Halbleiter-Unternehmen, verzeichnet aktuell eine gemischte Kursentwicklung. Am 12. Oktober 2024 fiel der Aktienkurs um 1,49% auf 0,66 EUR. Trotz dieses... ► Artikel lesen | |
NANOVIRICIDES | 1,250 | -3,85 % | NanoViricides President Dr. Diwan to Present at the PODD Conference | SHELTON, CT / ACCESSWIRE / October 22, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that... ► Artikel lesen | |
FENDX TECHNOLOGIES | 0,119 | +3,93 % | FendX Technologies Inc.: FendX Announces Grant of Japanese Patent to Protect REPELWRAP Film | Oakville, Ontario--(Newsfile Corp. - October 29, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX") a nanotechnology company developing surface protection... ► Artikel lesen | |
NANOFOCUS | 1,330 | 0,00 % | EQS-Adhoc: NanoFocus AG: NanoFocus passt Prognose für 2024 an | EQS-Ad-hoc: NanoFocus AG / Schlagwort(e): Prognoseänderung
NanoFocus AG passt Prognose für 2024 an
28.10.2024 / 10:28 CET/CEST
Veröffentlichung einer Insiderinformation nach Artikel... ► Artikel lesen | |
ACACIA RESEARCH | 4,060 | -1,93 % | Acacia Research Corporation Acquires Deflecto | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, announced... ► Artikel lesen | |
NVE | 68,50 | 0,00 % | NVE Corporation Reports Second-Quarter Results and Announces Quarterly Dividend | EDEN PRAIRIE, Minn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter ended September 30, 2024. Total revenue for the second quarter... ► Artikel lesen | |
ADVANCE ZINCTEK | 0,422 | -5,38 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
LEHNER INVESTMENTS | 0,015 | -51,67 % | EQS-DD: LEHNER INVESTMENTS AG: RIMIVY LTD, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
05.07.2024 / 16:36... ► Artikel lesen | |
DOTZ NANO | 0,049 | 0,00 % | DOTZ NANO LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | ||
ZENTEK | 0,620 | -10,79 % | Zentek Ltd.: Zentek Provides Regulatory Update for ZenGUARD Enhanced Air Filters | GUELPH, ON / ACCESSWIRE / October 31, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it has... ► Artikel lesen | |
GOMSPACE | 0,370 | 0,00 % | GOMSPACE A/S: GomSpace North America Selected by Proteus Space's AI Design Platform for Groundbreaking Satellite Mission |